<VariationArchive VariationID="329511" VariationName="NM_000400.4(ERCC2):c.1479+2dup" VariationType="Duplication" Accession="VCV000329511" Version="17" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-17" DateCreated="2016-12-06" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="343775" VariationID="329511">
      <GeneList>
        <Gene Symbol="ERCC2" FullName="ERCC excision repair 2, TFIIH core complex helicase subunit" GeneID="2068" HGNC_ID="HGNC:3434" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="45349837" stop="45370573" display_start="45349837" display_stop="45370573" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="45854648" stop="45873844" display_start="45854648" display_stop="45873844" Strand="-" />
          </Location>
          <OMIM>126340</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000400.4(ERCC2):c.1479+2dup</Name>
      <CanonicalSPDI>NC_000019.10:45357267:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="45357267" stop="45357268" display_start="45357267" display_stop="45357268" variantLength="1" positionVCF="45357267" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="45860525" stop="45860526" display_start="45860525" display_stop="45860526" variantLength="1" positionVCF="45860525" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.45357268dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.45357268dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.45860526dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.45860526dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007067.2" sequenceAccession="NG_007067" sequenceVersion="2" change="g.18320dup">
            <Expression>NG_007067.2:g.18320dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000400.4" sequenceAccession="NM_000400" sequenceVersion="4" change="c.1479+2dup" MANESelect="true">
            <Expression>NM_000400.4:c.1479+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_461" sequenceAccession="LRG_461">
            <Expression>LRG_461:g.18320dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000400.3" sequenceAccession="NM_000400" sequenceVersion="3" change="c.1479+2dupT">
            <Expression>NM_000400.3:c.1479+2dupT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_461t1" sequenceAccession="LRG_461t1">
            <Expression>LRG_461t1:c.1479+2dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA9513280" DB="ClinGen" />
        <XRef Type="rs" ID="776705174" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00003" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1479+2dup AND ERCC2-related disorder" Accession="RCV000325544" Version="5">
        <ClassifiedConditionList TraitSetID="33624">
          <ClassifiedCondition DB="MedGen" ID="CN239291">ERCC2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-06-14" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1479+2dup AND Xeroderma pigmentosum" Accession="RCV000825518" Version="5">
        <ClassifiedConditionList TraitSetID="7951">
          <ClassifiedCondition DB="MedGen" ID="C0043346">Xeroderma pigmentosum</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-02-04" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1479+2dup AND not provided" Accession="RCV001753790" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-24" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1479+2dup AND Cerebrooculofacioskeletal syndrome 2" Accession="RCV003463783" Version="2">
        <ClassifiedConditionList TraitSetID="5505">
          <ClassifiedCondition DB="MedGen" ID="C1853102">Cerebrooculofacioskeletal syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-09" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2016-12-06" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(3); Likely pathogenic(2); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">17576681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7920640</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536098</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(3); Likely pathogenic(2); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2019-08-25">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7951" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="7021" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum</ElementValue>
                <XRef ID="Xeroderma+pigmentosum/7564" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019600" DB="MONDO" />
                <XRef ID="44600005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosa</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7910" />
                <XRef ID="7910" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="910" DB="Orphanet" />
              <XRef ID="C0043346" DB="MedGen" />
              <XRef ID="MONDO:0019600" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="33624" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36488" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ERCC2-related conditions</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ERCC2-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">ERCC2-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ERCC2-Related Disorders</ElementValue>
              </Name>
              <XRef ID="CN239291" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5505" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="765" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cerebrooculofacioskeletal syndrome 2</ElementValue>
                <XRef ID="Cerebrooculofacioskeletal+syndrome+2/7946" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012553" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">COFS2</ElementValue>
                <XRef Type="MIM" ID="610756" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15497" />
                <XRef ID="15497" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C1853102" DB="MedGen" />
              <XRef ID="MONDO:0012553" DB="MONDO" />
              <XRef Type="MIM" ID="610756" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="727093" SubmissionDate="2016-10-18" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="825532|ERCC2-Related Disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000413572" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="2" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7920640</ID>
          </Citation>
          <Comment>The c.1479+2dupT variant is reported in one study in which it was found in two unrelated individuals with trichothiodystrophy who were both compound heterozygous for the c.1479+2dupT variant, one with a deletion variant on the second allele and one with a missense variant (Broughton et al. 1994). Both individuals displayed a DNA repair deficiency. Control data are not available for this variant, which is reported at a frequency of 0.00002 in the European (Non-Finnish) population of the Exome Aggregation Consortium database. This frequency is based on one allele only so the variant is presumed to be rare. RT-PCR studies showed an 18 bp deletion due to the c.1479+2dupT variant resulting in an in-frame loss of six amino acids in exon 15. Based on the limited evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for ERCC2-related disorders.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification 20161018</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/r4jv4v98/icsl_variant_classification_20161018.pdf</URL>
            <CitationText>ICSL_Variant_Classification_20161018.pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.3:c.1479+2dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ERCC2-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ICSL_2016Q4</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1894626" SubmissionDate="2019-03-21" DateLastUpdated="2019-08-26" DateCreated="2019-08-26">
        <ClinVarSubmissionID localKey="85020375|Orphanet:ORPHA910" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000966832" DateUpdated="2019-08-26" DateCreated="2019-08-26" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7920640</ID>
          </Citation>
          <Comment>The c.1479+2dupT variant in ERCC2 has been reported in 2 individuals with Xerode rma pigmentosum, including in trans with a truncating allele in one individual ( Broughton 1994), and has been reported in ClinVar (Variation ID: 329511). The va riant has been identified in 2/110536 European chromosomes by the Genome Aggrega tion Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs776705174). Pl ease note that for diseases with clinical variability, reduced penetrance, or re cessive inheritance, pathogenic variants may be present at a low frequency in th e general population. This variant occurs in the invariant region (+/- 1,2) of t he splice consensus sequence and is predicted to cause altered splicing leading to an abnormal or absent protein. In vitro data suggest this variant results in the deletion of 18 nucleotides, corresponding to an in-frame deletion. In summar y, although additional studies are required to fully establish its clinical sign ificance, the c.1479+2dupT variant is likely pathogenic. ACMG/AMP Criteria appli ed: PM2; PM3; PM4.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000400.3:INTRON 15</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_000400.3:c.1479+2dupT</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.45860525_45860526insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Xeroderma pigmentosum</ElementValue>
            </Name>
            <XRef DB="Orphanet" ID="ORPHA910" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348959</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3882520" SubmissionDate="2021-11-17" DateLastUpdated="2023-03-04" DateCreated="2021-11-06">
        <ClinVarSubmissionID localKey="GDXSV:213927" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001987433" DateUpdated="2023-03-04" DateCreated="2021-11-06" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Canonical splice site variant expected to result in aberrant splicing. Functional studies have demonstrated two mRNA products are created; one with loss of exon 15 and another with an 18bp deletion due to use of a cryptic site (Broughton et al., 1994); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 7920640, 31980526)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="19" alternateAllele="A" referenceAllele="-" start="45860525" stop="45860526" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2711338</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_64_20211030201206</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_71_20211117054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7182483" SubmissionDate="2023-03-16" DateLastUpdated="2023-03-26" DateCreated="2023-03-26">
        <ClinVarSubmissionID localKey="NM_000400.3:c.1479+2dupT|MedGen:C0043346" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003844275" DateUpdated="2023-03-26" DateCreated="2023-03-26" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7920640</ID>
          </Citation>
          <Comment>Variant summary: ERCC2 c.1479+2dupT alters a nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes the canonical 5' splicing donor site and one predicts the variant weakens the canonical 5' donor site. This variant has been found to affect mRNA splicing, resulting in loss of exon 15 or the last 18 nucleotides of exon 15 due to use of a cryptic splice site (Broughton_1994). The variant allele was found at a frequency of 4e-06 in 248778 control chromosomes (gnomAD). c.1479+2dupT has been reported in the literature in individuals affected with trichothiodystrophy (Broughton_1994). These data indicate that the variant may be associated with disease. Four ClinVar submitters have assessed the variant since 2014: one classified the variant as uncertain significance, one as likely pathogenic, and two as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.3:c.1479+2dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043346" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12956415</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6132931" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4957129|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003443399" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7920640</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17576681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9536098</ID>
          </Citation>
          <Comment>This sequence change falls in intron 15 of the ERCC2 gene. It does not directly change the encoded amino acid sequence of the ERCC2 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs776705174, gnomAD 0.002%). This variant has been observed in individual(s) with trichothiodystrophy (PMID: 7920640). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as +T insertion in splice donor site of intron 15. ClinVar contains an entry for this variant (Variation ID: 329511). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.45860525_45860526insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7840669" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000400.4:c.1479+2dup|OMIM:610756" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004194631" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.4:c.1479+2dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610756" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7840669" TraitType="Disease" MappingType="XRef" MappingValue="610756" MappingRef="OMIM">
        <MedGen CUI="C1853102" Name="Cerebrooculofacioskeletal syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1894626" TraitType="Disease" MappingType="Name" MappingValue="Xeroderma pigmentosum" MappingRef="Preferred">
        <MedGen CUI="C0043346" Name="Xeroderma pigmentosum" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6132931" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="727093" TraitType="Disease" MappingType="Name" MappingValue="ERCC2-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="CN239291" Name="ERCC2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7182483" TraitType="Disease" MappingType="XRef" MappingValue="C0043346" MappingRef="MedGen">
        <MedGen CUI="C0043346" Name="Xeroderma pigmentosum" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3882520" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002022194</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

